Pictet North America Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-10,000
Closed -$802K 175
2018
Q2
$802K Hold
10,000
0.12% 79
2018
Q1
$803K Buy
10,000
+6,000
+150% +$250K 0.12% 78
2017
Q4
$345K Sell
4,000
-680
-15% -$31.4K 0.05% 110
2017
Q3
$465K Buy
+4,680
New +$226K 0.07% 88

Other funds holding SNY

Pictet North America Advisors's SNY Position: Q3 2018 in Review

Pictet North America Advisors sold out of Sanofi (SNY) in Q3 2018, closing a stake of 10,000 shares — an estimated $802K sold.

Pictet North America Advisors first reported a position in SNY in Q3 2017 and held it in 4 quarters. The position peaked at $803K in Q1 2018. 481 funds tracked by Wall St. Rank hold SNY as of Q3 2018.

  • Pictet North America Advisors reported no remaining Sanofi position as of Q3 2018 after selling out during the quarter.
  • Pictet North America Advisors sold 10,000 Sanofi shares in Q3 2018, an estimated $802K.
  • Pictet North America Advisors first reported a position in Sanofi in Q3 2017 and held it in 4 quarters.
  • Pictet North America Advisors's Sanofi position peaked at $803K in Q1 2018.
  • 481 funds tracked by Wall St. Rank held Sanofi as of Q3 2018.

Based on Pictet North America Advisors's 13F filing for Q3 2018, filed 7 Nov 2018.